Israel Englander Adamas Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	N/A	-146,750 Closed	0 $0
Q1 2021 May 17, 2021	BUY	N/A	146,750 New	146,750 $704,000
Q3 2019 Nov 14, 2019	SELL	N/A	-325,417 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	N/A	-11,308,465 Reduced 97.2%	325,417 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	N/A	10,615,899 Added 1042.84%	11,633,882 $74.6 Million
Q1 2019 May 14, 2019	BUY	N/A	538,084 Added 112.12%	1,017,983 $7.24 Million
Q4 2018 Feb 14, 2019	BUY	N/A	229,404 Added 91.58%	479,899 $4.1 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-91,685 Reduced 26.79%	250,495 $5.02 Million
Q2 2018 Aug 14, 2018	BUY	N/A	260,360 Added 318.21%	342,180 $8.84 Million
Q1 2018 May 15, 2018	SELL	N/A	-575,263 Reduced 87.55%	81,820 $1.96 Million
Q4 2017 Feb 14, 2018	SELL	N/A	-603,496 Reduced 47.87%	657,083 $22.3 Million
Q3 2017 Nov 14, 2017	BUY	N/A	1,260,579	1,260,579 $26.7 Million

About Adamas Pharmaceuticals, Inc.

Ticker ADMS
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,408,100
Market Cap $376M

More about ADMS

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.